Grainger D J, Witchell C M, Watson J V, Metcalfe J C, Weissberg P L
Department of Biochemistry, University of Cambridge, United Kingdom.
Cardiovasc Res. 1993 Dec;27(12):2238-47. doi: 10.1093/cvr/27.12.2238.
Various heparins have been reported to inhibit the proliferation of vascular smooth muscle cells (VSMCs). The effects of eight chemically distinct heparins on the cell cycle and differentiation of primary and passaged cultures of rat aortic VSMCs have been characterised and the mechanism of heparin action investigated.
VSMCs from adult rat aorta were prepared by enzyme dispersion and stimulated to enter the cell cycle with 10% serum in the presence or absence of heparin. Progressions through S phase and M phase were measured by [3H]-thymidine incorporation and cell counting respectively. Flow cytometry was used to confirm the effects of heparin on VSMC cell cycle progression. The effect of heparin on VSMC differentiation was investigated by analysing smooth muscle specific myosin heavy chain content of the cells after heparin treatment.
Eight heparins at concentrations between 5 micrograms.ml-1 and 100 micrograms.ml-1 partially inhibited VSMC proliferation (27% to 76% 96 hours after addition of heparin), but did not affect the entry of the cells into S phase. Flow cytometry confirmed that VSMC populations in the presence of heparin contained significantly (p < 0.005) more cells in the G2/M phase of the cell cycle than control populations. Heparin also blocked the dedifferentiation of primary cultures of VSMCs stimulated by serum. These effects of heparin were completely reversed by the presence of a neutralising antiserum to transforming growth factor beta (TGF beta) and heparin attached to agarose beads was as effective as free heparin as a growth inhibitor of VSMCs.
Heparins of varying molecular weight and anticoagulant properties all partially inhibited VSMC proliferation predominantly by extending the G2/M phase of the cell cycle. Heparin also inhibited dedifferentiation of primary cultures of VSMCs. Heparin (< 100 micrograms.ml-1) acted extracellularly to release TGF beta from serum, which accounted for the effects of heparin on proliferation and differentiation.
已有报道称多种肝素可抑制血管平滑肌细胞(VSMC)的增殖。本研究对八种化学结构不同的肝素对大鼠主动脉VSMC原代培养和传代培养的细胞周期及分化的影响进行了表征,并对肝素的作用机制进行了研究。
通过酶分散法制备成年大鼠主动脉的VSMC,在有或无肝素存在的情况下,用10%血清刺激其进入细胞周期。分别通过[3H] - 胸腺嘧啶核苷掺入法和细胞计数法测定S期和M期的进程。采用流式细胞术确认肝素对VSMC细胞周期进程的影响。通过分析肝素处理后细胞中平滑肌特异性肌球蛋白重链含量,研究肝素对VSMC分化的影响。
浓度在5微克/毫升至100微克/毫升之间的八种肝素部分抑制了VSMC增殖(添加肝素后96小时抑制率为27%至76%),但不影响细胞进入S期。流式细胞术证实,存在肝素时VSMC群体中处于细胞周期G2/M期的细胞明显多于对照群体(p < 0.005)。肝素还可阻断血清刺激的VSMC原代培养物的去分化。抗转化生长因子β(TGFβ)中和抗血清可完全逆转肝素的这些作用,且琼脂糖珠结合的肝素作为VSMC生长抑制剂与游离肝素同样有效。
不同分子量和抗凝特性的肝素均主要通过延长细胞周期的G2/M期部分抑制VSMC增殖。肝素还可抑制VSMC原代培养物的去分化。肝素(<100微克/毫升)在细胞外发挥作用,从血清中释放TGFβ,这解释了肝素对增殖和分化的影响。